Apax: Latest generics takeover Invent Farma will include API division Inke

Apax: Latest generics takeover Invent Farma will include API division Inke

Inke's manufacturing operations are in Castellbisbal, Spain which is 20 Kms from Barcelona. The facility employs around 30 people.

According to Inke's website, the active pharmaceutical ingredients (APIs) are made by Invent at its neighboring laboratories. Inke had passed an inspection by the US Food and Drug Administration (FDA) with no form 483s being issued, which was the fifth time the division has been visited by the US regulator since 2002.

Inke sells 13 different APIs in the US according to Invent.

The spokeswoman for the firm told us "We have a broad customer base worldwide. . "

Second CNS investment in a month

In a previous release the Invent group said it generated revenue of € 100m last year with 40% of its sales coming from the rest of the European Union, Japan and the US. >

Apax's decision to buy

This fits with the funds takeover of Germany-based generic drug manufacturer Neuraxpharm Arzneimittel this month.

Both spokesperson for a therapeutic focus as - like Qualigen - Neuraxpharm specializes in the production of drugs for central nervous system disorders. Apax Partners declined to comment when asked for more information.

Related:

Comments